Patient Toll-Free Number: 866.651.6272

covid-19 & vaccinations quality improvement activity (QIA)

The COVID-19 pandemic impacted Americans across the country and further threatened the health of patients living with chronic conditions. ESRD patients carry a greater risk of mortality and morbidity if contracted with COVID-19. Thankfully, three vaccine variations are readily available to the public to decrease the spread and severity of the virus. Vaccine hesitancy can be linked to lack of education and the spread of false information. To overcome this barrier, we must work diligently to encourage, educate, and inform our ESRD patients about the benefits of vaccination. In addition to COVID-19, patients remain at risk for contracting flu and pneumonia. The Network will provide continuous support to patients, providers, and facilities so that together, we can keep patients with complex, chronic conditions protected and informed.

  • Achieve a 5% decrease in the number of ESRD patients hospitalized with COVID- 19
  • Ensure at least 80% of dialysis patients receive a COVID-19 vaccination
  • Ensure at least 85% of dialysis patients receive an influenza vaccination
  • Ensure at least 90% of dialysis facility staff receive an influenza vaccination
  • Report staff influenza vaccinations in the National Healthcare Safety Network (NHSN)
  • Achieve a 10% increase in the number of patients receiving a pneumococcal conjugate vaccination (PCV) 13
  • Ensure 87% of dialysis patients receive a pneumococcal polysaccharide vaccine (PPSV) 23
  • Achieve a 10% increase in the number of patients receiving a booster PPSV 23
  • Ensure 80% of dialysis patients over 65 years old receive a PPSV 23
  • Provide counts of nursing home patients and number of nursing homes monthly


Coming Soon


  • Project Attestation Form - Coming soon
  • Root Cause Analysis (RCA) - Coming soon
  • Monthly Reporting (PDSA) - Coming soon





Network 5 Contact

Amanda Morelli, MSN, RN
Phone: (804) 320-0004 x2709